Spencer Ryan

CIK 00017779382 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001777938

Recent Transactions

50 trades

Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−11,100→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−4,250→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−2,125→ 0 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2025-06-18+11,100→ 11,100 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-18+55,000→ 297,261 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2025-02-18−55,000→ 110,000 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-18$12.93/sh−36,528→ 260,733 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-13$12.69/sh−31,694→ 242,261 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2025-02-13−62,500→ 0 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2025-02-13+62,500→ 62,500 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-13+62,500→ 273,522 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2025-02-13+225,000→ 225,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2025-02-13+136,000→ 136,000 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-10$13.20/sh−11,209→ 211,022 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2025-02-10+20,833→ 222,231 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2025-02-10−20,833→ 0 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-07-18+2,125→ 2,125 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-04-26+4,250→ 4,250 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-02-15$9.45/sh+402→ 201,030 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Options (Right to Buy)
2024-02-15+231,000→ 231,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2024-02-15+165,000→ 165,000 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-02-12$12.82/sh−11,684→ 200,628 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2024-02-10−20,833→ 20,833 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-02-10+20,833→ 212,312 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-02-05$12.79/sh−17,129→ 191,479 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2024-02-04−29,750→ 0 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2024-02-04+29,750→ 208,608 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27+29,750→ 193,132 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27$10.36/sh−14,673→ 178,459 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27+20,834→ 174,019 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27$10.36/sh−4,670→ 153,185 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2023-02-27−20,834→ 41,666 total
Tax Payment
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27$10.36/sh−10,637→ 163,382 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-27+9,888→ 157,855 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2023-02-27−29,750→ 29,750 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Stock Option (Right to Buy)
2023-02-16+280,000→ 280,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2023-02-15$9.73/sh+1,786→ 147,967 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2022-12-09+9,888→ 9,888 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2022-08-15$10.29/sh+1,668→ 146,181 total
Sale
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2022-08-09$16.92/sh−14,921→ 144,513 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2022-08-08+29,663→ 159,434 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2022-08-08+29,663→ 9,887 total
Sale
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2022-03-03$10.56/sh−52,835→ 129,771 total
Sale
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2022-03-03$10.57/sh−17,611→ 182,606 total
Sale
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2022-03-03$10.57/sh−12,662→ 170,467 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2022-03-02−29,750→ 59,500 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Restricted Stock Unit
2022-03-02−20,833→ 0 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2022-03-02+20,833→ 183,129 total
Exercise/Conversion
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2022-03-02+29,750→ 200,217 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Common Stock
2022-02-15$10.29/sh+1,457→ 162,296 total

Companies

Recent Filings

Address

C/O CIDARA THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE SUITE 101

SAN DIEGO, CA, 92121

View on SEC.gov